CrowdStrike Stock Is Up 150% Over The Last Year. Why It’s Poised For Another Big Move.

The market is voting, and CrowdStrike stock is the clear leader in the cybersecurity group. “There is a lot of strength there,” Irusha Peiris, portfolio manager at O’Neil Global Advisors, told Investor’s Business Daily’s “Investing with IBD” podcast. “There were a number of names out there that were doing well, and they all kind of … Read more

State of Oregon fights Frank Gable over compensation for wrongful conviction, imprisonment

PORTLAND, Ore. (Portland Tribune) — The Oregon Department of Justice is fighting Frank Gable’s request for compensation for being wrongly convicted and imprisoned for killing Oregon Corrections Director Michael Francke. Gable has filed a petition in Marion County Circuit Court seeking $2 million under an Oregon law that allows compensation to individuals who can prove … Read more

Only ‘Doomsday Scenario’ Would Spur South African DA-ANC Tie-Up

(Bloomberg) — South Africa’s main opposition Democratic Alliance may consider entering a coalition with the ruling African National Congress to avoid the country being governed by more leftist parties after this year’s election. Most Read from Bloomberg A “doomsday scenario” in which the ANC teams up with the Economic Freedom Fighters or the Jacob Zuma-backed … Read more

Crispr Stock, A Cathie Wood’s Holding, Dives For The Fifth Straight Week — Here’s Why

Crispr stock is tumbling for the fifth straight week as the top Cathie Wood’s holding struggles amid dimming expectations for its new Vertex-partnered gene-editing drug. X Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) gained Food and Drug Administration approval for Casgevy on Dec. 8. On the same day, the FDA signed off on a rival … Read more